Streetbeat News

ONTTF

Oxford Nanopore Technologies Plc

Industry

Testing Laboratories

Open

1.83

Mkt cap

1.7B

Volume

11K

High

1.90

P/E Ratio

-7.04

52-wk high

2.70

Low

1.80

Div yield

N/A

52-wk low

1.10

Oxford Nanopore has announced a strategic partnership with the UK Government to advance genomics-driven healthcare innovation. This collaboration involves Genomics England, UK Biobank, and NHS England, aiming to enhance genomics-based research and healthcare in the UK.

Portfolio Pulse from

November 05, 2024 | 12:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.